This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Fusion Antibodies Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Leona McGirr: Innovator in Antibody Library Technology
Introduction
Leona McGirr is a prominent inventor based in Belfast Antrim, GB. She has made significant contributions to the field of biotechnology, particularly in the development of antibody libraries. Her innovative work has the potential to enhance the efficiency of antibody binding and improve therapeutic outcomes.
Latest Patents
Leona McGirr holds a patent for an "Antibody library and method." This invention relates to methods of generating antibody libraries, which are crucial for identifying variants with improved binding characteristics. The patent outlines a novel approach that involves using nucleotide sequences to create a small library of antibody variants, incorporating mutations recognized by deamination somatic hypermutation enzymes. This technique has demonstrated a relatively high proportion of variants with increased affinity, showcasing its effectiveness in enhancing antibody performance.
Career Highlights
Throughout her career, Leona has been associated with Fusion Antibodies Limited, where she has applied her expertise in antibody technology. Her work has contributed to advancements in the field, particularly in the context of affinity maturation assays. Leona's innovative methods have the potential to streamline the process of identifying high-affinity antibodies, which is essential for therapeutic applications.
Collaborations
Leona McGirr has collaborated with notable colleagues, including Richard John Buick and Christopher Scott. These collaborations have fostered a dynamic environment for innovation and have contributed to the success of her projects.
Conclusion
Leona McGirr is a trailblazer in the field of antibody technology, with a focus on improving the efficiency of antibody libraries. Her patent and collaborative efforts highlight her commitment to advancing biotechnology and enhancing therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile